Roche Urges Fed. Circ. To Revive Boniva Patents
Hoffmann-La Roche Inc. on Monday urged the Federal Circuit to overturn a ruling that found two patents covering its osteoporosis drug Boniva invalid for obviousness, part of a dispute with several...To view the full article, register now.
Already a subscriber? Click here to view full article